Select the name of the type of clinical care program you would like more information about …

Example: ‘B’ for Bladder Cancer

Cancer Treatment A-Z

Skip to content. | Skip to navigation

Personal tools


You are here: Home
31 items matching your search terms.
Filter the results.
Item type

New items since

Sort by relevance · date (newest first) · alphabetically
Cancer patient out-of-pocket costs play major role in treatment adherence
by William Shawn Davis (wishda) published Jan 09, 2014 — filed under:
The cost of insurance co-payments for cutting-edge pharmaceuticals can vary widely from patient to patient. When the patient’s share of prescription costs becomes too high, many patients skip doses or stop taking medication entirely, according to research conducted at the University of North Carolina.
Located in News
UNC Lineberger members awarded grants from N.C. Biotechnology Center
by William Shawn Davis published Aug 23, 2013 last modified Aug 26, 2013 09:20 AM — filed under:
The North Carolina Biotechnology Center awarded more than $460,000 in grants to support research and infrastructure needs of members of the UNC Lineberger Comprehensive Cancer Center researching cancer and cell biology.
Located in News
Transcription factors regulating blood oxygen linked to melanoma metastases
by William Shawn Davis published Apr 19, 2013 last modified May 08, 2013 02:40 PM — filed under:
Transcription factors regulating blood oxygen linked to melanoma metastases
Located in News
Novel monoclonal antibody inhibits tumor growth in breast cancer and angiosarcoma
by William Davis published Apr 30, 2013 last modified May 08, 2013 02:09 PM — filed under:
A monoclonal antibody targeting a protein known as SFPR2 has been shown by researchers at the University of North Carolina to inhibit tumor growth in pre-clinical models of breast cancer and angiosarcoma.
Located in News
Basch: Patient participation must play a larger role in research
by William Shawn Davis published May 13, 2013 last modified May 13, 2013 04:05 PM — filed under:
Patients must take a larger role in participating in and assisting in determining priorities for medical research, according to an editorial published in an upcoming issue of the Journal of the American Medical Association.
Located in News
NIH and UNC Researchers Define Role of Protein Vinculin in Cell Movement
by William Shawn Davis (wishda) published Aug 14, 2013 last modified Aug 14, 2013 09:53 AM — filed under:
Researchers at the University of North Carolina and the National Institutes for Health have defined the role of the protein vinculin in enabling cell movement. In a paper published in the Journal of Cell Biology, Sharon Campbell, PhD, professor of Biochemistry and Biophysics and member of UNC Lineberger Comprehensive Cancer Center, and Clare Waterman of the National Heart, Lung and Blood Institute at the National Institutes of Health showed that cell mobility occurs through the interactions between the protein vinculin and the cytoskeletal lattice formed by the protein actin. By physically binding to the actin that makes up the cytoskeleton, vinculin operates as a form of molecular clutch transferring force and controlling cell motion.
Located in News
Inhibiting Macrophage MerTK Signaling Creates an Innate Immune Response Against Cancer
by Megan Fazekas-King (fazekask) published Jul 29, 2013 — filed under:
The tyrosine kinase MerTK plays a prominent role in the body’s immune response. MerTK signaling helps “calm” the body’s first line of immunity, the macrophage, while it performs the routine duties - clearing cells that die and healing damaged tissue.
Located in News
Komen awards more than $800,000 to UNC Lineberger researchers
by William Shawn Davis (wishda) published Aug 02, 2013 last modified Aug 02, 2013 12:59 PM — filed under:
Susan G. Komen for the Cure has awarded more than $800,000 to researchers with the UNC Lineberger Comprehensive Cancer Center to fund research into fighting cancer.
Located in News
Goldstein profiled in The Journal of Cell Biology
by William Shawn Davis (wishda) published Aug 09, 2013 last modified Aug 09, 2013 11:24 AM — filed under:
Bob Goldstein, PhD, professor of biology, talks about his career and the promise of cell biology in a profile in the August issue of The Journal of Cell Biology.
Located in News
DeSimone microneedle patch featured in ScienceNews
by William Shawn Davis (wishda) published Aug 12, 2013 — filed under:
A rapidly-dissolvable microneedle patch developed by a UNC team led by Joseph DeSimone, William R. Kenan, Jr. Distinguished Professor of Chemistry and Chemical Engineering, and director of the UNC Institute for Advanced Materials, Nanoscience, and Technology and member of UNC Lineberger, allows for painless injections of medicine and vaccines.
Located in News